We are an ETH Zurich spin-off developing tracers for the early diagnosis of neurodegenerative diseases including Alzheimer's Disease and Multiple Sclerosis
📢Innovator announcement📢
Dr. Hazem Ahmed is a clinical scientist with a mission to revolutionize the diagnosis and treatment of Alzheimer’s Disease (AD) & other neurodegenerative diseases. He will be honoured at this years #MITIU35Europe 11th-12th May👉 https://t.co/ZR0zjqcC5T
CONGRATULATIONS! The 7 winners of the 2022 W.A. #devigier Awards are: ALIVION, Composite Recycling, Impossible Materials, InCephalo, NematX AG, Nemosia and PIPRA! Thanks everyone for a fabulous award ceremony and CHEERS to supporting #swissstartups !
CHF 40,000 for 3 medtech startups from @EPFL and @ETH Zürich: ArcoScreen, Nemosia, and Parithera win the next stage of Venture Kick! Congratulations!
Read: https://t.co/gw45sn1ka6
#VentureKick#SwissStartups#Medtech#Switzerland
Accelerating Swiss hightech for wheelchairs, neurological disease detection, and urban planning intelligence: startups Exomotion, Nemosia, UrbanDataLab, and Uzufly win CHF 10,000 and enter Venture Kick!
Congrats to the teams of founders: https://t.co/A4nPdOVZmO
#VentureKick